Patents by Inventor Ramus Vendler Toft-Kehler

Ramus Vendler Toft-Kehler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HALOGENATED SALICYLANILIDES FOR TREATING CLOSTRIDIUM INFECTIONS
    Publication number: 20210308153
    Abstract: The present invention relates to halogenated salicylanilides, or pharmaceutically acceptable salts or esters thereof, for use in the treatment of an infection in a subject caused by Clostridium bacteria, particularly a C. difficile infection. The halogenated salicylanilides are expected to be useful in the treatment of C. difficile associated diseases including C. difficile associated diarrhoea and C. difficile associated colitis.
    Type: Application
    Filed: November 6, 2020
    Publication date: October 7, 2021
    Inventors: Morten Otto Alexander Sommer, Ramus Vendler Toft-Kehler, Daniel Jean Jacques Simon
  • Halogenated salicylanilides for treating infections
    Patent number: 10857164
    Abstract: The present invention relates to halogenated salicylanilides, or pharmaceutically acceptable salts or esters thereof, for use in the treatment of an infection in a subject caused by Clostridium bacteria, particularly a C. difficile infection. The halogenated salicylanilides are expected to be useful in the treatment of C. difficile associated diseases including C. difficile associated diarrhoea and C. difficile associated colitis.
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: December 8, 2020
    Assignee: UNION therapeutics A/S
    Inventors: Morten Otto Alexander Sommer, Ramus Vendler Toft-Kehler, Daniel Jean Jacques Simon
  • HALOGENATED SALICYLANILIDES FOR TREATING CLOSTRIDIUM INFECTIONS
    Publication number: 20200093839
    Abstract: The present invention relates to halogenated salicylanilides, or pharmaceutically acceptable salts or esters thereof, for use in the treatment of an infection in a subject caused by Clostridium bacteria, particularly a C. difficile infection. The halogenated salicylanilides are expected to be useful in the treatment of C. difficile associated diseases including C. difficile associated diarrhoea and C. difficile associated colitis.
    Type: Application
    Filed: October 1, 2019
    Publication date: March 26, 2020
    Inventors: Morten Otto Alexander Sommer, Ramus Vendler Toft-Kehler, Daniel Jean Jacques Simon